Eton Pharmaceuticals (ETON) EBT Growth (1y) (2019 - 2025)
Eton Pharmaceuticals (ETON) EBT Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 48.64% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -1.94% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -24.84% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -23.88% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1,578.91% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 45.00% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -342.95% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 62.03% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -267.87% |
| 10 | Eton Pharmaceuticals | 806.97 Mn | 781.03 Mn | 13.10 Mn | 376.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 376.71% |
| Sep 30, 2025 | -490.22% |
| Jun 30, 2025 | 15.67% |
| Mar 31, 2025 | -84.71% |
| Dec 31, 2024 | 74.56% |
| Sep 30, 2024 | 186.53% |
| Jun 30, 2024 | -165.52% |
| Mar 31, 2024 | 69.51% |
| Dec 31, 2023 | -320.29% |
| Sep 30, 2023 | 80.99% |
| Jun 30, 2023 | 392.62% |
| Mar 31, 2023 | 50.09% |
| Dec 31, 2022 | -12.22% |
| Sep 30, 2022 | 50.03% |
| Jun 30, 2022 | 22.72% |
| Mar 31, 2022 | -204.18% |
| Dec 31, 2021 | 113.52% |
| Sep 30, 2021 | 6.30% |
| Jun 30, 2021 | 57.38% |
| Mar 31, 2021 | 156.54% |